FDA agrees to speed review for an ultra-rare disease drug Stealth BioTherapeutics had said it may have to shutter if endorsement isn’t made in coming weeks

https://www.statnews.com/pharmalot/2025/08/21/fda-rare-disease-medicine-pharma-biotech-stealth-barth/